ELSEVIER (Academic Press Imprint)

Series: NEXT GENERATION TECHNOLOGY DRIVEN PERSONALIZED MEDICINE AND SMART HEALTHCARE

Call for Chapters:

THE FUTURE OF PHARMA ACROSS ALL SECTORS IN THE ARTIFICIAL INTELLIGENCE ERA

The pharmaceutical industry is undergoing a profound transformation fueled by rapid advancements in technology, evolving patient needs, and dynamic market landscapes. This edited volume, "The Future of Pharma Across All Sectors in the Artificial Intelligence Era," aims to present a holistic perspective on the current and future state of the pharmaceutical sector. It explores the role of Artificial Intelligence (AI) and other groundbreaking technologies in redefining research, development, manufacturing, and healthcare delivery.

This book invites contributions from researchers, industry experts, healthcare professionals, and academicians to provide in-depth insights, innovative solutions, and thought-provoking analyses. By capturing a broad spectrum of challenges, opportunities, and trends, the volume seeks to equip stakeholders with actionable strategies and inspire forward-looking discussions on navigating the pharmaceutical industry's future.

Objectives of the Volume

• To explore how AI and emerging technologies are revolutionizing the pharmaceutical industry.
• To examine the impact of digital transformation and precision medicine on patient care, drug development, and delivery.
• To analyze regulatory trends and compliance challenges in an AI-driven era.
• To discuss innovations in manufacturing, supply chain, and global health solutions.
• To identify future trends and predictions for a sustainable and inclusive pharmaceutical industry.

Indicative Topics

Introduction to the Future of Pharma

• Evolution and future outlook of the pharmaceutical industry.
• The role of AI and digital transformation in shaping pharma’s future.

Technological Advancements

• Breakthrough innovations in drug discovery, nanotechnology, and bioinformatics.
• Machine learning, robotics, and automation in pharmaceutical R&D.

Precision Medicine

• Tailoring medical treatments to individual patient profiles.
• AI’s role in genomic analysis and biomarker discovery.

Digital Transformation

• Leveraging AI for enhanced drug development and clinical trials.
• The impact of digital health tools on patient engagement and outcomes.

Regulatory Trends and Compliance

• Navigating regulatory changes in an AI-driven pharmaceutical ecosystem.
• Ethical considerations and compliance in the adoption of new technologies.

Drug Development and Personalized Therapies

• Advances in targeted therapies and immunotherapy.
• AI-driven modeling and simulations in drug formulation.

Manufacturing, Supply Chain, and Distribution

• Smart manufacturing practices using AI and IoT technologies.
• Strategies for enhancing pharmaceutical supply chain resilience and security.

Healthcare Access and Affordability

• Addressing disparities in drug accessibility and affordability globally.
• Leveraging AI to promote equitable healthcare delivery.

Global Health Challenges and Emerging Threats

• AI in combating infectious diseases, pandemics, and emerging global health threats.
• Cross-sectoral collaborations for scalable and innovative health solutions.

Future Trends and Predictions

• AI’s role in quantum computing applications in pharmaceuticals.
• Predicting the next paradigm shifts in drug discovery and healthcare innovation.

Market Dynamics and Commercial Strategies

• Adapting to market changes with robust AI-enabled commercial strategies.
• Real-world case studies on successful AI integration in pharma.

Submission Guidelines

This book will be published by Elsevier (Academic Press Imprint) as part of the "Next Generation Technology Driven Personalized Medicine and Smart Healthcare" series. Contributors must adhere to the following submission requirements:

• Abstracts: No more than 500 words, clearly articulating the chapter's scope and significance.
• Full Chapters: 6,000 to 8,000 words, including references, tables, and figures.
• Originality: Submissions must be original and not under consideration elsewhere.
• Formatting: Use APA 7th edition for citations and formatting.

Important Deadlines

Event

Date

Chapter Peoposal Submission

January 30, 2024

Notification of Acceptance

Febraury 15, 2024

Full Chapter Submission

March 30, 2025

Review Results

April 25, 2025

Final Chapter Submission

May 15, 2025

Publication Date

Q4, 2025

Editors

· Dr. Miltiadis Lytras, Computer Science Department, College of Engineering, Effat University, Saudi Arabia

· Dr. Ahmed M. Shaman, Department of Clinical Pharmacy, King Saud University, Riyadh, Saudi Arabia

· Dr. Paraskevi Papadopoulou, Deree-The American College of Greece, Athens, Greece

· Dr. Patricia Ordonez de Pablos, Facultad de Economia y Empresa, Universidad de Oviedo, Oviedo, Spain

· Dr. Sofia Konstantinopoulou, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

· PharmaD. Sarah Abdulrahman Alajlan, Faculty of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia

Chapter proposal submissions: [email protected]